chartexchange

EDSA
Edesa Biotech, Inc. Common Shares
stockNASDAQ

Market OpenNov 16, 2026 10:09:08 AM EST
1.78USD-7.990%(-0.16)95,108
Pre-marketNov 16, 2026 8:45:30 AM EST
1.8712USD-3.546%(-0.0688)
1.5400Bid2.0600Ask0.5200Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Markham, ON, Canada
Previous Close
$1.95
Beta
-0.31
52-Week High
$20.32 2026-05-01
52-Week Low
$0.72 2026-02-20
SMA 50
$3.29
SMA 200
$5.70
Avg. Vol 10D
8.90M
Avg. Vol 30D
3.00M
Avg. Vol 90D
1.04M
Relative Vol
0.02
7.68M
14.8300%
2,911
Dec 11, 2026 (25d)
Oct 11, 2023 · 1-for-7 (reverse)
EDSA Profile

founded in 2015, edesa biotech brings innovative new treatments for dermatological and anorectal diseases. late-stage prescription drugs developed by edesa biotech aim to help patients who experience limited treatment options. edesa biotech's focus on dermatology is led by an experienced team that have licensed global rights to clinical stage assets for dermatology and anorectal indications.

EDSA Performance
PeriodPriceDateChangeBeta
1W2.492026-11-09-27.91%12.258
1M2.572026-10-16-30.16%1.984
3M5.652026-08-17-68.23%1.742
6M13.052026-05-15-86.25%0.877
1Y1.742025-11-17+3.46%-0.312
2Y2.102024-11-15-14.52%—
5Y47.532021-11-16-96.22%0.838
EDSA Stock Summary

Edesa Biotech, Inc. Common Shares (NASDAQ:EDSA) stock price today is $1.80, and today's volume is 60,671. EDSA is down 7.474% today. The 30 day average volume is 3.00M. EDSA market cap is $17.31M with 9.64M shares outstanding.